CYTEGRITY

Serial Number 98232780
730

Registration Progress

Application Filed
Oct 20, 2023
Under Examination
Jul 8, 2025
Approved for Publication
May 13, 2025
Published for Opposition
May 13, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Jul 08, 2026 199 days

Trademark Image

CYTEGRITY

Basic Information

Serial Number
98232780
Filing Date
October 20, 2023
Published for Opposition
May 13, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Dec 8, 2025
Application
Pending
Classes
035 040 042 045

Rights Holder

CSL Behring Gene Therapy, Inc.

03
Address
Suite 650
35 N. Lake Avenue
Pasadena, CA 91101

Ownership History

CSL Behring Gene Therapy, Inc.

Original Applicant
03
Pasadena, CA

CSL Behring Gene Therapy, Inc.

Owner at Publication
03
Pasadena, CA

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

Next Deadline
199 days remaining
NOA E-Mailed - SOU Required
Due Date
July 08, 2026
Extension Available
Until January 08, 2027

Application History

27 events
Date Code Type Description Documents
Dec 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 8, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 8, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 13, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 13, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 7, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 15, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 14, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 14, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 14, 2025 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Jan 14, 2025 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jan 14, 2025 GNFR O FINAL REFUSAL E-MAILED Loading...
Jan 14, 2025 CNFR R FINAL REFUSAL WRITTEN Loading...
Dec 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 11, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 11, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 11, 2024 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 11, 2024 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 13, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 13, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 5, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 25, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 24, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business consultation in the field of business process improvement for clinical manufacturing
Class 040
Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; Biomanufacturing for others, namely, manufacturing of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of cell lines and cells using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of biological preparations for use in industry and science, and cell cultures for medical purposes using biological organisms or viruses in the manufacturing process; Biomanufacturing process consulting
Class 042
Scientific and pharmaceutical research and development; medical research; biological research; Scientific laboratory services in in the field of viral vectors and gene therapy vectors; Scientific, pharmaceutical, and medical research in the field of bioproduction, regulatory pathway services, accessory proteins and alternative envelope proteins; Scientific research consulting in the field of clinical manufacturing
Class 045
Regulatory compliance consulting in the field of clinical manufacturing

Classification

International Classes
035 040 042 045